<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01537224</url>
  </required_header>
  <id_info>
    <org_study_id>2011-A00392-39</org_study_id>
    <nct_id>NCT01537224</nct_id>
  </id_info>
  <brief_title>Electrophysiological Activity of the Subthalamic Nucleus During the Processing of Emotional and Motivational Information</brief_title>
  <acronym>EMOPHYSIO</acronym>
  <official_title>Study of the Electrophysiological Activity of the Subthalamic Nucleus During the Processing of Emotional and Motivational Information in Patients With Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <brief_summary>
    <textblock>
      The role of the basal ganglia in the processing of information with emotional or motivational&#xD;
      content has been demonstrated by several lesion and functional imaging studies in humans and&#xD;
      animals. Deep brain stimulation surgery provides an opportunity to study these structures in&#xD;
      humans in electrophysiological terms. The aim of this study is to investigate modifications&#xD;
      in the electrophysiological activity of the subthalamic nucleus (STN) during the perception&#xD;
      of auditory and visual stimuli with emotional or motivational connotations in patients with&#xD;
      Parkinson's disease who have just undergone implantation of a deep brain stimulator in the&#xD;
      STN.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2011</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">September 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Electrophysiological activity of the subthalamic nucleus</measure>
    <time_frame>5 days</time_frame>
    <description>Electrophysiological activity of the subthalamic nucleus will be measured during the perception of auditory and visual stimuli with emotional or motivational connotations in patients with Parkinson disease who have just undergone implatation of a deep brain stimulator in the subthalamic nucleus</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Parkinson</condition>
  <arm_group>
    <arm_group_label>neurostimulation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Measure of the electrophysiological activity of the subthalamic nucleus</intervention_name>
    <description>Local field recording of the subthalamic nucleus by mean of externalized electrodes in the immediate postoperative periode.</description>
    <arm_group_label>neurostimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient with Parkinson's disease selected for deep brain stimulation (DBS) of the&#xD;
             subthalamic nucleus (STN) in accordance with the criteria established by Welter and&#xD;
             colleagues (Welter et al., 2002);&#xD;
&#xD;
          -  Aged 18 years or above;&#xD;
&#xD;
          -  Written informed consent from the patient.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient under a legal incapacity or with limited legal capacity;&#xD;
&#xD;
          -  Patient who has perioperative complications or postoperative confusion;&#xD;
&#xD;
          -  Patient displaying cognitive disturbances involving the early stages of speech&#xD;
             processing (on the basis of an audiogram systematically conducted prior to surgery) ;&#xD;
&#xD;
          -  Patient displaying cognitive disturbances involving the early stages of face&#xD;
             processing (on the basis of the Benton Facial Recognition Test (Benton, Hamsher,&#xD;
             Varney, &amp; Spreen, 1983) systematically administered prior to surgery);&#xD;
&#xD;
          -  Patient incapable of understanding the information given about the study, performing&#xD;
             the tasks or providing informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc Verin, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paul Sauleau, MD, PhD</last_name>
    <email>paul.sauleau@chu-rennes.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <study_first_submitted>February 10, 2012</study_first_submitted>
  <study_first_submitted_qc>February 22, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 23, 2012</study_first_posted>
  <last_update_submitted>November 30, 2012</last_update_submitted>
  <last_update_submitted_qc>November 30, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 3, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Electrophysiology</keyword>
  <keyword>Subthalamic nucleus</keyword>
  <keyword>Parkinson</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

